Who owns IP

A new era for Europe?

The 2024 European Parliament highlights emerging right-wing influence and pressing issues from climate action to youth voter disengagement.

Global perspectives on the state of intellectual property

(more…)

Recent work has strengthened the intellectual property rights ecosystem to protect traditional knowledge from commercial patents.

(more…)

China’s muscling into the pharmaceutical industry, helping Big Pharma bite back against generics. But its global ambitions might turn the industry upside down.

(more…)

IP laws are supposed to work to aid pharmaceutical innovation in rich nations. Can a new system support treating illnesses rife in developing economies, too?

(more…)

Unequal access to the COVID-19 vaccine fuelled calls for a patent waiver, but any major change needs to ensure a better outcome for developing economies.

(more…)

A battle between PepsiCo and Indian farmers highlights the gap between international trade law and countries seeking to protect their farmers’ seed rights.

(more…)

Changes to a global agreement allowing compulsory licensing of COVID-19 vaccines do nothing to improve access in developing economies. Cost is still a barrier.

(more…)

Public money directly and indirectly supports pharmaceutical innovation. Governments need to ensure the public gets a fair return on its investment.

(more…)